Literature DB >> 22007645

Serum aldosterone is associated with inflammation and aortic stiffness in normotensive overweight and obese young adults.

Jennifer N Cooper1, Ping Tepper, Emma Barinas-Mitchell, Genevieve A Woodard, Kim Sutton-Tyrrell.   

Abstract

Circulating aldosterone is increased in obesity and is associated with arterial stiffening in hypertensives and older adults. The aim of this article was to determine whether serum aldosterone is associated with pulse wave velocity (PWV), a measure of arterial stiffness, in normotensive overweight and obese adults aged 20-45 years (n = 344). Heart-femoral, femoral-ankle, and brachial-ankle PWV were measured. The sample was 77% female with mean body mass index 32.9 kg/m(2) (SD 3.9), median serum aldosterone 106.5 pg/mL (interquartile range 79.9, 155.5), and mean 24-hour urinary sodium excretion 185.9 mEq/day (SD 69.6). Higher serum aldosterone was not significantly correlated with any PWV measure in bivariate analysis. However, in multiple linear regression, adjusting for age, sex, race, height, heart rate, mean arterial pressure, and waist circumference, higher log aldosterone was associated with greater log heart-femoral PWV (β(se) = 0.042(0.021), P = .049). After adjusting for C-reactive protein, this association was no longer significant (β(se) = 0.035(0.021), P = .10). Circulating aldosterone may play an important role in vascular inflammation and aortic stiffening in normotensive overweight and obese adults.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22007645      PMCID: PMC3262912          DOI: 10.3109/10641963.2011.618200

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  44 in total

1.  The association between the renin-angiotensin-aldosterone system and arterial stiffness in young healthy subjects.

Authors:  Y Shapiro; M Boaz; Z Matas; A Fux; M Shargorodsky
Journal:  Clin Endocrinol (Oxf)       Date:  2008-01-10       Impact factor: 3.478

Review 2.  Aldosterone and vascular inflammation.

Authors:  Nancy J Brown
Journal:  Hypertension       Date:  2008-01-02       Impact factor: 10.190

3.  Pancreatic renin-angiotensin-aldosterone system in the cardiometabolic syndrome and type 2 diabetes mellitus.

Authors:  Melvin R Hayden; James R Sowers
Journal:  J Cardiometab Syndr       Date:  2008

4.  Regional arterial stiffness in patients with type 2 diabetes and chronic kidney disease.

Authors:  Eiji Kimoto; Tetsuo Shoji; Kayo Shinohara; Sawako Hatsuda; Katsuhito Mori; Shinya Fukumoto; Hidenori Koyama; Masanori Emoto; Yasuhisa Okuno; Yoshiki Nishizawa
Journal:  J Am Soc Nephrol       Date:  2006-07-12       Impact factor: 10.121

5.  A possible association between primary aldosteronism and a lower beta-cell function.

Authors:  Lorena M Mosso; Cristian A Carvajal; Alberto Maiz; Eugenia H Ortiz; Carmen R Castillo; Rocío A Artigas; Carlos E Fardella
Journal:  J Hypertens       Date:  2007-10       Impact factor: 4.844

Review 6.  Aldosterone and the vascular system.

Authors:  Victoria Cachofeiro; Maria Miana; Natalia de Las Heras; Beatriz Martín-Fernández; Sandra Ballesteros; Jesús Fernández-Tresguerres; Vicente Lahera
Journal:  J Steroid Biochem Mol Biol       Date:  2008-03-06       Impact factor: 4.292

7.  The influence of serum aldosterone and the aldosterone-renin ratio on pulse wave velocity in hypertensive patients.

Authors:  Sungha Park; Jin-Bae Kim; Chi Young Shim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Namsik Chung
Journal:  J Hypertens       Date:  2007-06       Impact factor: 4.844

Review 8.  Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.

Authors:  Shawna A Cooper; Adam Whaley-Connell; Javad Habibi; Yongzhong Wei; Guido Lastra; Camila Manrique; Sameer Stas; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-06-22       Impact factor: 4.733

Review 9.  The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.

Authors:  Jennifer M Perkins; Stephen N Davis
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2008-04       Impact factor: 3.243

10.  Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism.

Authors:  Giampaolo Bernini; Fabio Galetta; Ferdinando Franzoni; Michele Bardini; Chiara Taurino; Melania Bernardini; Lorenzo Ghiadoni; Matteo Bernini; Gino Santoro; Antonio Salvetti
Journal:  J Hypertens       Date:  2008-12       Impact factor: 4.844

View more
  16 in total

1.  Associations between arterial stiffness and platelet activation in normotensive overweight and obese young adults.

Authors:  Jennifer N Cooper; Rhobert W Evans; Maria Mori Brooks; Linda Fried; Chris Holmes; Emma Barinas-Mitchell; Kim Sutton-Tyrrell
Journal:  Clin Exp Hypertens       Date:  2013-05-08       Impact factor: 1.749

2.  Changes in serum aldosterone are associated with changes in obesity-related factors in normotensive overweight and obese young adults.

Authors:  Jennifer N Cooper; Linda Fried; Ping Tepper; Emma Barinas-Mitchell; Molly B Conroy; Rhobert W Evans; Maria Mori Brooks; Genevieve A Woodard; Kim Sutton-Tyrrell
Journal:  Hypertens Res       Date:  2013-05-09       Impact factor: 3.872

3.  Reductions in arterial stiffness with weight loss in overweight and obese young adults: potential mechanisms.

Authors:  Jennifer N Cooper; Jeanine M Buchanich; Ada Youk; Maria Mori Brooks; Emma Barinas-Mitchell; Molly B Conroy; Kim Sutton-Tyrrell
Journal:  Atherosclerosis       Date:  2012-05-30       Impact factor: 5.162

4.  Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice.

Authors:  Vincent G DeMarco; Javad Habibi; Guanghong Jia; Annayya R Aroor; Francisco I Ramirez-Perez; Luis A Martinez-Lemus; Shawn B Bender; Mona Garro; Melvin R Hayden; Zhe Sun; Gerald A Meininger; Camila Manrique; Adam Whaley-Connell; James R Sowers
Journal:  Hypertension       Date:  2015-05-26       Impact factor: 10.190

5.  Aldosterone, inactive matrix gla-protein, and large artery stiffness in hypertension.

Authors:  Julio A Chirinos; Mayank Sardana; Amer Ahmed Syed; Maheshwara R Koppula; Swapna Varakantam; Izzah Vasim; Harold G Oldland; Timothy S Phan; Nadja E A Drummen; Cees Vermeer; Raymond R Townsend; Scott R Akers; Wen Wei; Edward G Lakatta; Olga V Fedorova
Journal:  J Am Soc Hypertens       Date:  2018-06-30

Review 6.  Obesity and cardiovascular disease in women.

Authors:  Camila Manrique-Acevedo; Bhavana Chinnakotla; Jaume Padilla; Luis A Martinez-Lemus; David Gozal
Journal:  Int J Obes (Lond)       Date:  2020-02-17       Impact factor: 5.095

7.  Smooth muscle cell mineralocorticoid receptors are mandatory for aldosterone-salt to induce vascular stiffness.

Authors:  Anne Pizard; Alexandre Gueret; Guillaume Galmiche; Soumaya El Moghrabi; Antoine Ouvrard-Pascaud; Stefan Berger; Pascal Challande; Iris Z Jaffe; Carlos Labat; Patrick Lacolley; Frédéric Jaisser
Journal:  Hypertension       Date:  2013-12-02       Impact factor: 10.190

8.  Repeatability of Central and Peripheral Pulse Wave Velocity Measures: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Michelle L Meyer; Hirofumi Tanaka; Priya Palta; Mehul D Patel; Ricky Camplain; David Couper; Susan Cheng; Ada Al Qunaibet; Anna K Poon; Gerardo Heiss
Journal:  Am J Hypertens       Date:  2015-07-31       Impact factor: 2.689

Review 9.  Aldosterone and vascular mineralocorticoid receptors: regulators of ion channels beyond the kidney.

Authors:  Jennifer J DuPont; Michael A Hill; Shawn B Bender; Frederic Jaisser; Iris Z Jaffe
Journal:  Hypertension       Date:  2013-12-30       Impact factor: 10.190

10.  Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial.

Authors:  Andreas Tomaschitz; Astrid Fahrleitner-Pammer; Burkert Pieske; Nicolas Verheyen; Karin Amrein; Eberhard Ritz; Katharina Kienreich; Jörg H Horina; Albrecht Schmidt; Elisabeth Kraigher-Krainer; Caterina Colantonio; Andreas Meinitzer; Stefan Pilz
Journal:  BMC Endocr Disord       Date:  2012-09-13       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.